MENU
+Compare
PASG
Stock ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$6.27
Change
+$0.66 (+11.76%)
Capitalization
19.56M

PASG Passage Bio Inc Forecast, Technical & Fundamental Analysis

Passage Bio Inc is a genetic medicines company... Show more

PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PASG with price predictions
Aug 08, 2025

PASG's RSI Indicator ascending out of oversold territory

The RSI Indicator for PASG moved out of oversold territory on July 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In of the 38 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PASG just turned positive on August 08, 2025. Looking at past instances where PASG's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

PASG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PASG as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PASG moved below its 50-day moving average on July 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PASG crossed bearishly below the 50-day moving average on July 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PASG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PASG entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.419) is normal, around the industry mean (18.712). P/E Ratio (0.000) is within average values for comparable stocks, (55.605). PASG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.011). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (287.742).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PASG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PASG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PASG is expected to report earnings to fall 20.00% to -20 cents per share on November 18

Passage Bio Inc PASG Stock Earnings Reports
Q3'25
Est.
$-0.20
Q1'25
Est.
$-0.25
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.08
Q2'24
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 18.70K shares outstanding, the current market capitalization sits at 19.56M.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTD1255.9719.01
+1.54%
Mettler-Toledo International
NPWR2.69-0.01
-0.37%
NET Power
PGNY22.85-0.21
-0.91%
Progyny
TRUG5.09-0.16
-3.05%
TruGolf Holdings Inc
RAPT9.81-0.44
-4.29%
RAPT Therapeutics Inc

PASG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
+11.75%
AXON - PASG
43%
Loosely correlated
-3.27%
CYTK - PASG
38%
Loosely correlated
-3.23%
ARRY - PASG
35%
Loosely correlated
-5.82%
FBIO - PASG
33%
Loosely correlated
-1.62%
VYGR - PASG
33%
Loosely correlated
-2.48%
More